首页> 外文期刊>Oncology Research >Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion
【24h】

Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion

机译:抑制SLC34A2抑制肝癌细胞的增殖和侵袭

获取原文
获取原文并翻译 | 示例
       

摘要

The gene solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), is a member of the SLC34 family. Increasing evidence suggests that SLC34A2 is involved in the development of many human carcinomas. However, its role in hepatocellular carcinoma (HCC) is still unclear. Therefore, in this study we investigated the role of SLC34A2 in HCC and explored the underlying mechanism. We found that the expression of SLC34A2 is upregulated in HCC cell lines. Knockdown of SLC34A2 obviously inhibited HCC cell proliferation, migration/invasion, and the epithelial-mesenchymal transition (EMT) phenotype. Furthermore, knockdown of SLC34A2 significantly inhibited the expression of phosphorylated PI3K and AKT in HCC cells. Taken together, these results suggest that knockdown of SLC34A2 inhibits proliferation and migration by suppressing activation of the PI3K/AKT signaling pathway in HCC cells, and SLC34A2 may be a potential therapeutic target for the treatment of HCC.
机译:溶质载体家族34(磷酸钠)基因2(SLC34A2)是SLC34家族的成员。越来越多的证据表明SLC34A2参与了许多人类癌症的发展。但是,其在肝细胞癌(HCC)中的作用仍不清楚。因此,在这项研究中,我们调查了SLC34A2在肝癌中的作用并探讨了其潜在机制。我们发现SLC34A2的表达在HCC细胞系中被上调。击倒SLC34A2明显抑制HCC细胞增殖,迁移/侵袭和上皮-间质转化(EMT)表型。此外,敲低SLC34A2可以显着抑制HCC细胞中磷酸化PI3K和AKT的表达。综上所述,这些结果表明,SLC34A2的敲低通过抑制HCC细胞中PI3K / AKT信号通路的激活来抑制增殖和迁移,并且SLC34A2可能是治疗HCC的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号